Overview
Tonix Pharmaceuticals is a CNS-focused biopharmaceutical company developing Tonmya (TNX-102 SL), a sublingual cyclobenzaprine formulation for fibromyalgia and post-traumatic stress disorder.
More in Neuropharmaceuticals
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
2026-07-11 ยท Funding
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
2026-07-10 ยท Industry
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
2026-07-09 ยท Policy
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 ยท Policy
Company details
Category
๐ Neuropharmaceuticals
Location
New York, NY, USA
Funding
Public
Website
www.tonixpharma.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ